Pharmaceutical

Rafael Holdings and Cyclo Therapeutics enter merger deal

Rafael Holdings has signed a definitive merger agreement with Cyclo Therapeutics aiming to enhance the development of Trappsol Cyclo.

Aug 25, 2024 - 04:00
Rafael Holdings and Cyclo Therapeutics enter merger deal
Rafael Holdings has signed a definitive merger agreement with Cyclo Therapeutics aiming to enhance the development of Trappsol Cyclo.
Read the original article

Tags:

Previous Article

A comprehensive guide to supply chain management for specialty drugs

Next Article

VION Biosciences acquires Echelon Biosciences

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Boston Scientific’s drug-coated balloon may reduce risk of heart attack

STAT+: Boston Scientific’s drug-coated balloon may redu...

Oct 26, 2023

BeiGene secures accelerated FDA approval for follicular lymphoma treatment

BeiGene secures accelerated FDA approval for follicular...

Mar 9, 2024

Opinion: More hospitals are offering child care. But they shouldn’t have to

Opinion: More hospitals are offering child care. But th...

May 31, 2023